CN1294003A - Chinese patent medicine for promoting blood air circulation and building up bone and its preparing process - Google Patents
Chinese patent medicine for promoting blood air circulation and building up bone and its preparing process Download PDFInfo
- Publication number
- CN1294003A CN1294003A CN 99122099 CN99122099A CN1294003A CN 1294003 A CN1294003 A CN 1294003A CN 99122099 CN99122099 CN 99122099 CN 99122099 A CN99122099 A CN 99122099A CN 1294003 A CN1294003 A CN 1294003A
- Authority
- CN
- China
- Prior art keywords
- gram
- radix
- patent medicine
- medicine
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese patent medicine for promoting blood circulation and building up bone contains three groups of medicinal components. The first group includes 5 Chinese-medicinal materials including scorpion, centipede, etc. The second group contains 5 Chinese-medicinal materials including schizonepeta, pubescent angelica root, etc. The third group contains 4 Chinese patent medicines including glucurolactone, "654-2", etc. It features sure curative effect.
Description
The present invention relates to a kind of Chinese patent medicine and manufacture method thereof of having invigorated blood circulation.
Osteopathia such as hyperosteogeny, intervertebral disk hernia, rheumatism, rheumatoid inflammation and femur head necrosis are a kind of commonly encountered diseases.This disease course of disease is longer, deep-rooted, and be difficult to speed and remove, up to the present, the ideal medicine of inefficacy still clinically.
The purpose of this invention is to provide a kind of promoting blood air circulation and building up bone Chinese patent medicine for the treatment of above-mentioned disease, and the method for making this Chinese patent medicine is provided.
The present invention is achieved in that a kind of promoting blood air circulation and building up bone Chinese patent medicine, and it contains following 3 groups of pharmaceutical compositions (percentage by weight):
(1) first forms part: Scorpio 3.3-3.9%, Scolopendra 1.5-2.1%, Squama Manis 3.3-3.9%, Spina Gleditsiae 3.3-3.9%, Radix Angelicae Sinensis 0.9-1.5%, Rhizoma Chuanxiong 0.9-1.5%, Agkistrodon 7.3-10.6%, eupolyphaga 5.6-6.4%, Nidus Vespae 5.6-6.4%, Radix Aconiti Preparata 0.9-1.5%, Radix Aconiti Kusnezoffii Preparata 0.9-1.5%, Fructus Chaenomelis 2.4-3.0%, Radix Et Rhizoma Rhei 0.6-1.2%;
(2) second form part: Herba Schizonepetae 0.9-1.5%, anti-rich 0.9-1.5%, Radix Angelicae Pubescentis 1.5-2.1%, 0.6-1.2% lives, Radix Aconiti Lateralis Preparata 0.6-1.2%, Cortex Eucommiae 5.6-6.4%, Radix Dipsaci 0.9-1.5%, Radix Stephaniae Tetrandrae 0.9-1.5%, Herba Asari 0.6-1.2%, Olibanum (processed) 1.5-2.1%, Myrrha (processed) 1.5-2.1%, the careless 3.3-4.0% of old sight, Rhizoma Atractylodis 1.5-2.1%, Flos Carthami 1.5-2.1%, Semen Coicis 3.3-4.0%, Semen Persicae 0.9-1.5%, Radix Paeoniae Rubra 0.9-1.5%, Radix Astragali 2.4-3.0%, stir-baked RHIZOMA SPARGANII with vinegar 0.6-1.2%, vinegar Rhizoma Curcumae 0.6-1.2%, Semen Cuscutae 5.6-6.4%, Radix Cyathulae 1.5-2.1%, Radix Rehmanniae Preparata 3.3-4.0%, Fructus Corni 5.0-5.8%, Cortex Cinnamomi 0.9-1.5%;
(3) the 3rd form part: glucuronolatone patent medicine 2.1-2.7%, " 654-2 " patent medicine be below 0.1%, vitamin B
10.2-0.8%, indometacin 0.1-0.6%.
The manufacture method of above-mentioned Chinese patent medicine is: earlier first group of medicine being spent above Chinese liquor moxibustion shortcake with 50 respectively, be in the same place with second group of medicine and the 3rd group of medicament mixed then, is smalls altogether behind disinfection by ultraviolet light, incapsulates after the sterilization again.
The present invention adopts more than 40 kind of medicine according to the theory of " exhausted secret proved recipe arthromyodynia " " numbness is because of non-one, and is for a long time sick and cause, must be generous ", belongs to generously, but greatly and not disorderly, Wu Eryou advises.In its composition, Herba Schizonepetae, Fang Feng, Radix Angelicae Pubescentis, * * work, Radix Aconiti Preparata, Radix Aconiti Kusnezoffii Preparata, Herba Asari, old grass, Radix Stephaniae Tetrandrae, Rhizoma Atractylodis, Semen Coicis, Fructus Chaenomelis, Rhizoma Chuanxiong expelling wind and removing dampness, the dispersing cold for relieving pain seen; Scorpio, Scolopendra, Agkistrodon, eupolyphaga, Squama Manis, Nidus Vespae, Spina Gleditsiae are searched wind and are scraped bone; Join Olibanum, Myrrha, rhizoma sparganic, Rhizoma Curcumae, peach, Flos Carthami, Radix Paeoniae Rubra, Radix Cyathulae, Radix Dipsaci, Radix Et Rhizoma Rhei, strengthen the merit of its blood circulation promoting and blood stasis dispelling, removing obstruction in the collateral to relieve pain; Assistant is with the Radix Astragali, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, compensate qi and blood; Close Fructus Corni, Semen Cuscutae, the Cortex Eucommiae, Radix Aconiti Lateralis Preparata, Cortex Cinnamomi, reinforcing the kidney to strengthen the bone; Sneak into indometacin again to help the power of Chinese medicine wind-damp dispelling pain relieving; Patent medicine " 654-2 " can ease pain and expand littlely, and the effect of medicine-feeding blood circulation promoting and blood stasis dispelling is strengthened; Vitamin B
1Can promote carbohydrate metabolism, make nervous tissue obtain abundant nutrition, strengthen the effect of Chinese medicine revisal; Be aided with glucuronolatone, can with liver in and the poisonous substance of enteral combine, changes the glucose conjugate of unit's poison into and outside discharging, play protecting the liver and Detoxication when taking medicine for a long time, and glucuronolatone also has dispelling the wind and dampness pathogens pain, arthritic effect.Though medicament categories of the present invention is many, can bring out the best in each other, complement each other, embodied Chinese and Western and, met the generous traditional theory of controlling rheumatism involving the bone again with the principle of controlling pertinacious disease.Through thousands of routine clinical trials, Chinese patent medicine curative effect of the present invention is reliable, and the effect of expelling wind and removing dampness, dispersing cold for relieving pain, promoting blood air circulation and building up bone is arranged in fact.But osteoarthritis such as curing hyperosteogeny, intervertebral disk hernia, rheumatism, rheumatoid arthritis, sciatica, intractable cervical spondylosis, femur head necrosis.
Below be several embodiments of the present invention, when the numerical value in its bracket is produced this Chinese patent medicine for finger, the medicine material weight example that weighs.
Embodiment one: the promoting blood air circulation and building up bone Chinese patent medicine, contain first and form part: Scorpio 3.6% (60 gram), Scolopendra 1.8% (30 gram), Squama Manis 3.6% (60 gram), Spina Gleditsiae 3.6% (60 gram), Radix Angelicae Sinensis 1.2% (20 gram), Rhizoma Chuanxiong 1.2% (20 gram), Agkistrodon 9% (150 gram), eupolyphaga 6% (100 gram), Nidus Vespae 6% (100 gram), Radix Aconiti Preparata 1.2% (20 gram), Radix Aconiti Kusnezoffii Preparata 1.2% (20 gram), Fructus Chaenomelis 2.7% (45 gram), Radix Et Rhizoma Rhei 0.9% (15 gram);
Second forms part: Herba Schizonepetae 1.2% (20 gram), and anti-rich 1.2% (20 gram), Radix Angelicae Pubescentis 1.8% (30 gram),
*0.9% (15 gram) alive, Radix Aconiti Lateralis Preparata 0.9% (15 gram), the Cortex Eucommiae 6% (100 gram), Radix Dipsaci 1.2% (20 gram), Radix Stephaniae Tetrandrae 1.2% (20 gram), Herba Asari 0.9% (15 gram), Olibanum (processed) 1.8% (30 gram), Myrrha (processed) 1.8% (30 gram), the old grass 3.6% (60 gram) of seeing, Rhizoma Atractylodis 1.8% (30 gram), Flos Carthami 1.8% (30 gram), Semen Coicis 3.6% (60 gram), Semen Persicae 1.2% (20 gram), Radix Paeoniae Rubra 1.2% (20 gram), the Radix Astragali 2.7% (45 gram), stir-baked RHIZOMA SPARGANII with vinegar 0.9% (15 gram), vinegar Rhizoma Curcumae 0.9% (15 gram), Semen Cuscutae 6% (100 gram), Radix Cyathulae 1.8% (30 gram), Radix Rehmanniae Preparata 3.6% (60 gram), Fructus Corni 5.4% (90 gram), Cortex Cinnamomi 1.2% (20 gram);
(3) the 3rd form part: glucuronolatone patent medicine 2.4% (50 milligrams * 800), " 654-2 " patent medicine 0.09% (5 milligrams * 300), vitamin B
10.48% (10 milligrams * 800), indometacin patent medicine 0.45% (25 milligrams * 300).
The manufacture method of present embodiment Chinese patent medicine is that the Chinese liquor moxibustion shortcake more than earlier first group of medicine being spent with 50 respectively is in the same place with second group of medicine and the 3rd group of medicament mixed then, behind disinfection by ultraviolet light, be smalls altogether, the capsule of packing into No. 0 after the sterilization again, 0.5 system gram/grain specification.This medicine must careful usefulness for the gastric ulcer patient, the thing of period in a medicine diet wine, acid, stimulation such as peppery, cold.
Embodiment two:
First forms part: Scorpio 3.3% (55 gram), Scolopendra 2.1% (35 gram), Squama Manis 3.9% (65 gram), Spina Gleditsiae 3.3% (55 gram), Radix Angelicae Sinensis 0.9% (15 gram), Rhizoma Chuanxiong 1.5% (25 gram), Agkistrodon 10.6% (176 gram), eupolyphaga 5.6% (93 gram), Nidus Vespae 6.4% (107 gram), Radix Aconiti Preparata 1.5% (25 gram), Radix Aconiti Kusnezoffii Preparata 0.9% (15 gram), Fructus Chaenomelis 2.4% (40 gram), Radix Et Rhizoma Rhei 0.6% (10 gram);
Second forms part: Herba Schizonepetae 1.5% (25 gram), and anti-rich 1.5% (25 gram), Radix Angelicae Pubescentis 1.5% (25 gram),
*0.6% (10 gram) alive, Radix Aconiti Lateralis Preparata 0.6% (10 gram), the Cortex Eucommiae 6.4% (107 gram), Radix Dipsaci 0.9% (15 gram), Radix Stephaniae Tetrandrae 0.9% (15 gram), Herba Asari 1.2% (20 gram), Olibanum (processed) 1.5% (25 gram), Myrrha (processed) 2.1% (35 gram), the old grass 4% (67 gram) of seeing, Rhizoma Atractylodis 1.5% (25 gram), Flos Carthami 2.1% (35 gram), Semen Coicis 3.3% (55 gram), Semen Persicae 1.5% (25 gram), Radix Paeoniae Rubra 1.5% (25 gram), the Radix Astragali 2.4% (40 gram), stir-baked RHIZOMA SPARGANII with vinegar 0.6% (10 gram), vinegar Rhizoma Curcumae 1.2% (20 gram), Semen Cuscutae 5.6% (93 gram), Radix Cyathulae 2.1% (35 gram), Radix Rehmanniae Preparata 3.3% (55 gram), Fructus Corni 5.8% (97 gram), Cortex Cinnamomi 0.9% (15 gram);
(3) the 3rd form part: glucuronolatone patent medicine 2.1% (50 milligrams * 700), " 654-2 " patent medicine 0.1% (5 milligrams * 340), vitamin B
10.2% (10 milligrams * 330), indometacin patent medicine 0.1% (25 milligrams * 68).
Embodiment three:
First forms part: Scorpio 3.9% (65 gram), Scolopendra 1.5% (25 gram), Squama Manis 3.3% (55 gram), Spina Gleditsiae 3.9% (65 gram), Radix Angelicae Sinensis 1.5% (25 gram), Rhizoma Chuanxiong 0.9% (15 gram), Agkistrodon 7.3% (122 gram), eupolyphaga 6.4% (107 gram), Nidus Vespae 5.6% (93 gram), Radix Aconiti Preparata 0.9% (15 gram), Radix Aconiti Kusnezoffii Preparata 1.5% (25 gram), Fructus Chaenomelis 3% (50 gram), Radix Et Rhizoma Rhei 1.2% (20 gram);
Second forms part: Herba Schizonepetae 0.9% (15 gram), and anti-rich 0.9% (15 gram), Radix Angelicae Pubescentis 2.1% (35 gram),
*1.2% (20 gram) alive, Radix Aconiti Lateralis Preparata 1.2% (20 gram), the Cortex Eucommiae 5.6% (93 gram), Radix Dipsaci 1.5% (25 gram), Radix Stephaniae Tetrandrae 1.5% (25 gram), Herba Asari 0.6% (10 gram), Olibanum (processed) 2.1% (35 gram), Myrrha (processed) 1.5% (25 gram), the old grass 3.3% (55 gram) of seeing, Rhizoma Atractylodis 2.1% (35 gram), Flos Carthami 1.5% (25 gram), Semen Coicis 4% (67 gram), Semen Persicae 0.9% (15 gram), Radix Paeoniae Rubra 0.9% (15 gram), the Radix Astragali 3% (50 gram), stir-baked RHIZOMA SPARGANII with vinegar 1.2% (20 gram), vinegar Rhizoma Curcumae 0.6% (10 gram), Semen Cuscutae 1.5% (25 gram), Radix Cyathulae 1.5% (25 gram), Radix Rehmanniae Preparata 4% (67 gram), Fructus Corni 5% (83 gram), Cortex Cinnamomi 1.5% (25 gram);
(3) the 3rd form part: glucuronolatone patent medicine 2.7% (50 milligrams * 900), vitamin B
10.8% (10 milligrams * 1300), indometacin patent medicine 0.6% (25 milligrams * 400).
The Chinese patent medicine manufacture method of the foregoing description two and embodiment three is with embodiment one.
Claims (2)
1, a kind of promoting blood air circulation and building up bone Chinese patent medicine is characterized in that: it contains following 3 groups of pharmaceutical compositions (percentage by weight):
(1) first forms part: Scorpio 3.3-3.9%, Scolopendra 1.5-2.1%, Squama Manis 3.3-3.9%, Spina Gleditsiae 3.3-3.9%, Radix Angelicae Sinensis 0.9-1.5%, Rhizoma Chuanxiong 0.9-1.5%, Agkistrodon 7.3-10.6%, eupolyphaga 5.6-6.4%, Nidus Vespae 5.6-6.4%, Radix Aconiti Preparata 0.9-1.5%, Radix Aconiti Kusnezoffii Preparata 0.9-1.5%, Fructus Chaenomelis 2.4-3.0%, Radix Et Rhizoma Rhei 0.6-1.2%;
(2) second form part: Herba Schizonepetae 0.9-1.5%, anti-rich 0.9-1.5%, Radix Angelicae Pubescentis 1.5-2.1%, 0.6-1.2% lives, Radix Aconiti Lateralis Preparata 0.6-1.2%, Cortex Eucommiae 5.6-6.4%, Radix Dipsaci 0.9-1.5%, Radix Stephaniae Tetrandrae 0.9-1.5%, Herba Asari 0.6-1.2%, Olibanum (processed) 1.5-2.1%, Myrrha (processed) 1.5-2.1%, the careless 3.3-4.0% of old sight, Rhizoma Atractylodis 1.5-2.1%, Flos Carthami 1.5-2.1%, Semen Coicis 3.3-4.0%, Semen Persicae 0.9-1.5%, Radix Paeoniae Rubra 0.9-1.5%, Radix Astragali 2.4-3.0%, stir-baked RHIZOMA SPARGANII with vinegar 0.6-1.2%, vinegar Rhizoma Curcumae 0.6-1.2%, Semen Cuscutae 5.6-6.4%, Radix Cyathulae 1.5-2.1%, Radix Rehmanniae Preparata 3.3-4.0%, Fructus Corni 5.0-5.8%, Cortex Cinnamomi 0.9-1.5%;
(3) the 3rd form part: glucuronolatone patent medicine 2.1-2.7%, " 654-2 " patent medicine be below 0.1%, vitamin B
10.2-0.8%, indometacin 0.1-0.6%.
2, a kind of manufacture method of strong bone Chinese patent medicine is characterized in that: earlier first group of medicine being spent above Chinese liquor moxibustion shortcake with 50 respectively, be in the same place with second group of medicine and the 3rd group of medicament mixed then, is smalls altogether behind disinfection by ultraviolet light, incapsulates after the sterilization again.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 99122099 CN1294003A (en) | 1999-10-29 | 1999-10-29 | Chinese patent medicine for promoting blood air circulation and building up bone and its preparing process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 99122099 CN1294003A (en) | 1999-10-29 | 1999-10-29 | Chinese patent medicine for promoting blood air circulation and building up bone and its preparing process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1294003A true CN1294003A (en) | 2001-05-09 |
Family
ID=5282294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 99122099 Pending CN1294003A (en) | 1999-10-29 | 1999-10-29 | Chinese patent medicine for promoting blood air circulation and building up bone and its preparing process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1294003A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006076844A1 (en) * | 2005-01-18 | 2006-07-27 | Guangxi Huahong Pharmaceutical Co., Ltd. | Traditional chinese medicament for treating injuries from falls, rheumatism and ostealgia and method for manufacture thereof |
| CN102784256A (en) * | 2012-07-31 | 2012-11-21 | 李厚建 | Chinese medicine composition for treating arthralgia-synadrome |
| CN103768530A (en) * | 2014-02-11 | 2014-05-07 | 李兴富 | Pharmaceutical composition for treating osteoarthropathy as well as preparation method and application of pharmaceutical composition |
| CN104225464A (en) * | 2014-08-29 | 2014-12-24 | 韩世昌 | Plaster for treating sciatica and preparation method thereof |
| CN110478416A (en) * | 2019-09-27 | 2019-11-22 | 首都医科大学附属北京朝阳医院 | The composition and its preparation method and application for treating rheumatic rheumatoid arthritis |
-
1999
- 1999-10-29 CN CN 99122099 patent/CN1294003A/en active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006076844A1 (en) * | 2005-01-18 | 2006-07-27 | Guangxi Huahong Pharmaceutical Co., Ltd. | Traditional chinese medicament for treating injuries from falls, rheumatism and ostealgia and method for manufacture thereof |
| CN102784256A (en) * | 2012-07-31 | 2012-11-21 | 李厚建 | Chinese medicine composition for treating arthralgia-synadrome |
| CN102784256B (en) * | 2012-07-31 | 2014-05-28 | 吕红权 | Chinese medicine composition for treating arthralgia-synadrome |
| CN103768530A (en) * | 2014-02-11 | 2014-05-07 | 李兴富 | Pharmaceutical composition for treating osteoarthropathy as well as preparation method and application of pharmaceutical composition |
| CN103768530B (en) * | 2014-02-11 | 2016-05-11 | 李兴富 | A kind of pharmaceutical composition for the treatment of osteoarthrosis and its production and use |
| CN104225464A (en) * | 2014-08-29 | 2014-12-24 | 韩世昌 | Plaster for treating sciatica and preparation method thereof |
| CN110478416A (en) * | 2019-09-27 | 2019-11-22 | 首都医科大学附属北京朝阳医院 | The composition and its preparation method and application for treating rheumatic rheumatoid arthritis |
| CN110478416B (en) * | 2019-09-27 | 2021-10-08 | 首都医科大学附属北京朝阳医院 | Composition for treating rheumatic and rheumatoid arthritis and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1051237C (en) | Meicinal prepn. "Kexianling" for curing epilepsy | |
| CN100417401C (en) | Medicine for blood stanching, stasis transforming and bone joining | |
| CN1380095A (en) | Ointment for curing rheumatism and osteoarthropathy | |
| CN1294003A (en) | Chinese patent medicine for promoting blood air circulation and building up bone and its preparing process | |
| CN1290550C (en) | Chinese medicine composition for treating rheumatism, rheumatoid, hyperosteogeny and fracture and preparing method thereof | |
| CN1129130A (en) | Medicament for treatment of cervical spondylopathy | |
| CN1403139A (en) | Externally applied Chinese medicine for treating osteoarthropathy and its prepn process | |
| CN1491699A (en) | Medicinal formula for treating hyperosteogeny and prolapse of lumbar intervertebral disc | |
| CN1268385C (en) | Chinese medicinal for epilepsy and insanity | |
| CN1051506A (en) | A kind of preparation method of new type sanguisorba pharmaceutical | |
| CN1335147A (en) | Chinese medicine powder for treating tetanic rachitis | |
| CN1051471C (en) | Drug composition for curing osteoporosis | |
| CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
| CN1063088C (en) | Medicine for curing hepatic and gallbladder diseases | |
| CN1063086C (en) | Medicine for treatment of ischemic necrosis of fermoral head | |
| CN102228648A (en) | Chinese medicinal composition for treating icterohepatitis | |
| CN1215875C (en) | Peroral Chinese medicine powder for treating bone fracture and its preparing process | |
| CN101897924A (en) | Chinese medicinal preparation for treating biliary calculus | |
| CN1136899C (en) | Chinese medicine for treating mastoplasia | |
| CN1141801A (en) | Medicine for treatment of rheumatism and hyperosteogeny | |
| CN101057957A (en) | External applied traditional Chinese medicine lotion for treating osteoproliferation and bony spur | |
| CN1051468C (en) | Capsule for curing rheumatism | |
| CN100346807C (en) | Fuming-washing Chinese medicine for treating bone joint disease | |
| CN1279958A (en) | Medicine for curing osteomyelitis and its preparing method | |
| CN117018142A (en) | Bone injury ointment and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| BB1A | Publication of application | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |